Search

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH

Faster from Gene to Protein: Building Confidence into Every Development Decision

August 17, 2026

In drug discovery and development, critical decisions are only as good as the data supporting them. Whether selecting a lead candidate, validating a therapeutic target, or advancing a molecule into the next phase of development, researchers rely on proteins that accurately represent their intended biology.

Yet generating high-quality proteins is rarely a single-step process. It is a connected workflow that begins with gene design and continues through construct generation, expression, purification, and characterization. A challenge at any stage can delay downstream studies, create uncertainty in results, and slow program progress.

Why the Journey Matters as Much as the Protein 

Many protein-related challenges emerge long before a protein enters an assay. Suboptimal constructs can result in poor expression. Expression systems may not deliver the required functionality. Purification approaches that maximize yield may compromise stability or activity.

The result is often the same: teams spend valuable time investigating inconsistent assay outcomes, repeating experiments, or troubleshooting material quality instead of advancing their science.

For organizations operating under aggressive R&D timelines, these delays can affect milestone achievement, resource utilization, and the speed at which key development decisions are made.

The First Bottleneck Often Starts with Gene Synthesis

One of the earliest hurdles in any protein production workflow is generating the right gene construct. Traditionally, outsourced gene synthesis can add weeks to project timelines, limiting the ability to rapidly test new hypotheses, evaluate variants, or respond to evolving program needs.

To help customers accelerate this critical step, Aragen has brought gene synthesis in-house and can now synthesize genes up to 1.2 kb internally.

This capability reduces turnaround times from approximately three weeks to just 6-7 days from gene synthesis to protein expression, enabling faster progression from target sequence to experimental evaluation. More importantly, it allows closer coordination between gene synthesis, construct design, and protein production teams, reducing workflow interruptions and helping projects move forward more efficiently.

An Integrated Approach to Protein Production

The greatest value comes not from gene synthesis alone, but from its integration into a broader protein production strategy.

At Aragen, gene synthesis, construct generation, expression optimization, purification, and analytical characterization are connected within a single workflow and team. This enables teams to rapidly evaluate expression strategies, optimize construct designs when challenges arise, and generate proteins tailored to the specific requirements of downstream applications.

For customers, this enables:

  • Faster progression from sequence to purified protein
  • Greater flexibility when evaluating construct variants
  • Reduced dependency on multiple external vendors
  • Improved coordination across project stages
  • Higher confidence in the quality and suitability of generated proteins

Whether supporting target validation, hit discovery, antibody development, protein engineering, or biologics research, the goal remains the same: generating proteins that enable informed decisions.

From Protein Production to Decision Readiness

Decision-ready proteins are not defined solely by purity specifications or production yields. They are proteins generated through a thoughtful, end-to-end strategy that supports reproducibility, functionality, and scalability.

By combining in-house gene synthesis with integrated protein production expertise, Aragen helps customers reduce delays, accelerate learning cycles, and generate the reliable data needed to move programs forward with confidence.

Because in today’s development landscape, faster decisions do not come from speed alone. They come from having the right protein, generated the right way, from the very beginning.

Reviewed by

Srivats Rajagopal

Srivats Rajagopal

Senior Director, Cell and Protein Sciences

Aragen Life Sciences

Need faster, higher-quality protein production? Talk to Aragen to discuss your project needs.

FAQs

A decision-ready protein is a high-quality protein that generates reliable, reproducible data to support critical research and development decisions. It is functionally active, appropriately characterized, and produced using a strategy that can support future development needs.

Challenges such as poor expression, aggregation, instability, or inconsistent protein quality can lead to unreliable assay results and additional troubleshooting. These issues can slow target validation, candidate selection, and other key development milestones.

Gene synthesis is the foundation of protein production. The quality of the gene construct influences expression levels, protein functionality, and downstream purification outcomes. Starting with an optimized construct can significantly improve the likelihood of generating high-quality proteins.

By synthesizing genes up to 1.2 kb in-house, Aragen reduces turnaround times from approximately three weeks to just 6-7 days for many projects. This enables faster progression from sequence design to experimental evaluation while providing greater control over quality and project execution.

Protein production involves multiple interconnected steps, from gene synthesis and construct generation to expression, purification, and characterization. An integrated workflow helps reduce delays between stages, improves project coordination, and enables faster progression from sequence design to experimental data.

Aragen's integrated workflow, spanning gene synthesis, construct generation, protein expression, purification, and characterization, helps accelerate the production of high-quality proteins required for target validation, assay development, lead identification, and candidate evaluation. This enables customers to generate reliable data faster and make key program decisions with greater confidence.